Evofem Biosciences inks $25m

Evofem Biosciences Inc has secured $25 million in funding from Adjuvant Capital LP.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this